Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals Inc. did not get the RESULT it was looking for in a Phase III clinical trial testing Sollpura in the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibro

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

With input from Biomedtracker, Scrip highlights eight of the more interesting late-stage clinical trials due to read out in the next three months. vTv Therapeutics' Azeliragon vTv Therapeutics Inc

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c